Ying Xin Selected Research

Ying Xin Research Topics

Disease

48	Neoplasms (Cancer) 08/2022 - 12/2007
10	Inflammation (Inflammations) 10/2022 - 02/2013
8	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2008
7	Hypoxia (Hypoxemia) 05/2022 - 06/2010
6	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2018
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 11/2017
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2015 - 11/2007
5	Cardiomyopathies (Cardiomyopathy) 01/2021 - 08/2008
5	Fibrosis (Cirrhosis) 01/2020 - 04/2013
4	Carcinogenesis 08/2022 - 12/2011
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
4	Squamous Cell Carcinoma of Head and Neck 11/2021 - 01/2019
4	Gout 10/2020 - 05/2015
4	Body Weight (Weight, Body) 01/2020 - 10/2011
4	Cardiomegaly (Heart Hypertrophy) 10/2018 - 08/2008
4	Hypertension (High Blood Pressure) 01/2018 - 12/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2007
3	Papillary Thyroid Cancer 01/2022 - 01/2017
3	Ischemia 01/2021 - 06/2010
3	Wounds and Injuries (Trauma) 10/2019 - 08/2010
3	Osteosarcoma (Osteogenic Sarcoma) 08/2018 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2018 - 08/2010
3	Diabetic Cardiomyopathies 01/2018 - 02/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015 - 03/2010
2	Lung Neoplasms (Lung Cancer) 05/2022 - 08/2014
2	Macular Degeneration (Age-Related Maculopathy) 04/2022 - 01/2020
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2022 - 04/2014
2	Thyroid Neoplasms (Thyroid Cancer) 04/2022 - 12/2021
2	Thrombosis (Thrombus) 01/2022 - 09/2020
2	Melanoma (Melanoma, Malignant) 07/2021 - 06/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2021 - 08/2014
2	Atherosclerosis 03/2021 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 12/2018
2	Insulin Resistance 01/2021 - 03/2011
2	Obesity 01/2021 - 05/2018
2	Reperfusion Injury 01/2021 - 10/2016
2	Circulating Neoplastic Cells 10/2020 - 01/2019
2	Hyperuricemia 09/2020 - 01/2018
2	Neuroblastoma 05/2020 - 09/2007
2	Stomatitis 01/2020 - 10/2019
2	Malnutrition (Nutritional Deficiencies) 01/2020 - 12/2010
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2019 - 12/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 02/2013
2	Brain Ischemia (Cerebral Ischemia) 11/2018 - 10/2016
2	Hemorrhage 11/2017 - 06/2012
2	Hyperglycemia 01/2016 - 03/2015

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 08/2022 - 12/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
6	Uric Acid (Urate)IBA 10/2020 - 05/2015
5	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 02/2013
5	Histones (Histone)IBA 01/2022 - 01/2015
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
5	sulforaphaneIBA 01/2021 - 04/2013
5	Streptozocin (Streptozotocin)FDA Link 01/2018 - 09/2012
4	Angiotensin IIIBA 10/2022 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 11/2009
4	Messenger RNA (mRNA)IBA 01/2022 - 08/2008
4	Therapeutic UsesIBA 03/2015 - 03/2010
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2018
3	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2007
3	CytokinesIBA 01/2020 - 06/2010
3	ginsenoside Rg3IBA 06/2019 - 04/2007
3	Phosphotransferases (Kinase)IBA 02/2019 - 08/2008
3	MetallothioneinIBA 10/2018 - 03/2015
3	Oxygen (Dioxygen)IBA 10/2015 - 06/2010
2	AntioxidantsIBA 05/2022 - 06/2018
2	Small Interfering RNA (siRNA)IBA 04/2022 - 08/2008
2	IntegrinsIBA 04/2022 - 01/2021
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2022 - 06/2010
2	InterferonsIBA 04/2022 - 11/2007
2	Hormones (Hormone)IBA 01/2022 - 03/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 04/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2020
2	pembrolizumabIBA 12/2021 - 11/2021
2	NitrogenIBA 11/2021 - 11/2012
2	Everolimus FDA Link 07/2021 - 09/2011
2	Actins (F Actin)IBA 03/2021 - 01/2019
2	ProperdinIBA 03/2021 - 12/2018
2	Complement Factor D (Factor D)IBA 03/2021 - 12/2018
2	Complement C3 (C3 Complement)IBA 03/2021 - 12/2018
2	Complement System Proteins (Complement)IBA 03/2021 - 12/2018
2	Complement Factor H (Factor H)IBA 03/2021 - 12/2018
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2021 - 04/2010
2	SuspensionsIBA 10/2020 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 09/2020 - 09/2011
2	CollagenIBA 01/2020 - 04/2013
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2018
2	Disulfiram (Antabuse)FDA Link 01/2019 - 01/2019
2	CateninsIBA 08/2018 - 02/2018
2	Caspase 3 (Caspase-3)IBA 08/2018 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2018 - 05/2011
2	Insulin (Novolin)FDA Link 01/2016 - 03/2011
2	ZincIBA 03/2015 - 03/2014

Therapy/Procedure

21	Radiotherapy 05/2022 - 09/2017
13	Therapeutics 01/2022 - 12/2008
9	Drug Therapy (Chemotherapy) 11/2021 - 08/2014
3	Chemoradiotherapy 07/2021 - 01/2018
3	Transplantation 01/2020 - 01/2016
2	Immunotherapy 01/2021 - 01/2021